Anaesthesia and angiotensin II receptor antagonists

Anaesthesia

Volumn 55, Issue 10, 2000, Pages 1038-

  Macdonald, J M S ^a   Harmer, M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPHEDRINE; FENTANYL; METHOXAMINE; MIDAZOLAM; PHENYLEPHRINE; PROPOFOL; ROCURONIUM; TERLIPRESSIN; VASOPRESSIN;

ANESTHESIA INDUCTION; ARTHRITIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG EFFECT; DRUG EFFICACY; ENDOTRACHEAL INTUBATION; HEMODYNAMIC MONITORING; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTENSION; LETTER; LONG TERM CARE; PERIOPERATIVE PERIOD; SYSTOLIC BLOOD PRESSURE; URETEROSCOPY;

EID: 0033793581     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2000.01727-26.x     Document Type: Letter

References (4)

1. Medications to withhold or continue in the preoperative consultation
2. Perioperative management of drug therapy. Clinical considerations
3. Comparison of angiotensin receptor blockers: Impact of missed doses of candesartan cilexetil and losartan in systemic hypertension
4. The haemodynamic effects of anaesthetic induction in vascular patients chronically treated with angiotensin II receptor antagonists